Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Hemic or immune system
Reexamination Certificate
2010-02-17
2011-11-22
Belyavskyi, Michail (Department: 1644)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Hemic or immune system
Reexamination Certificate
active
08062675
ABSTRACT:
A method of enriching mesenchymal precursor cells including the step of enriching for cells based on at least two markers. The markers may be either i) the presence of markers specific for mesenchymal precursor cells, ii) the absence of markers specific for differentiated mesenchymal cells, or iii) expression levels of markers specific for mesenchymal precursor cells. The method may include a first solid phase sorting step utilising MACS recognising expression of the antigen to the STRO-1 Mab, followed by a second sorting step utilising two colour FACS to screen for the presence of high level STRO-1 antigen expression as well as the expression of VCAM-1.
REFERENCES:
patent: 5197985 (1993-03-01), Caplan et al.
patent: 5226914 (1993-07-01), Caplan et al.
patent: 5405772 (1995-04-01), Ponting et al.
patent: 5486359 (1996-01-01), Caplan et al.
patent: 5580754 (1996-12-01), Samal
patent: 5591625 (1997-01-01), Gerson et al.
patent: 5811094 (1998-09-01), Caplan et al.
patent: 5827740 (1998-10-01), Pittenger
patent: 5837539 (1998-11-01), Caplan et al.
patent: 5922597 (1999-07-01), Verfaillie et al.
patent: 5980887 (1999-11-01), Isner et al.
patent: 6022540 (2000-02-01), Bruder et al.
patent: 6087113 (2000-07-01), Caplan et al.
patent: 6261549 (2001-07-01), Fernandez et al.
patent: 6322784 (2001-11-01), Pittenger et al.
patent: 6335195 (2002-01-01), Rodgers et al.
patent: 6387367 (2002-05-01), Davis-Sproul et al.
patent: 6387369 (2002-05-01), Pittenger et al.
patent: 6645727 (2003-11-01), Thomas et al.
patent: 6709864 (2004-03-01), Pittenger et al.
patent: 6875430 (2005-04-01), McIntosh et al.
patent: 7122178 (2006-10-01), Simmons et al.
patent: 7670628 (2010-03-01), Simmons et al.
patent: 2002/0085996 (2002-07-01), McIntosh et al.
patent: 2004/0107453 (2004-06-01), Furcht et al.
patent: 2005/0019911 (2005-01-01), Gronthos et al.
patent: 2005/0158289 (2005-07-01), Simmons et al.
patent: 2005/0281790 (2005-12-01), Simmons et al.
patent: 2006/0008452 (2006-01-01), Simmons et al.
patent: 2006/0193840 (2006-08-01), Gronthos et al.
patent: 2006/0286077 (2006-12-01), Gronthos et al.
patent: 2007/0065938 (2007-03-01), Gronthos et al.
patent: 2007/0274958 (2007-11-01), Shi et al.
patent: WO 99/03973 (1999-01-01), None
patent: WO 00/06701 (2000-02-01), None
patent: WO 01/04268 (2001-01-01), None
patent: WO 01/11011 (2001-02-01), None
patent: WO 02/07679 (2002-01-01), None
patent: WO 2004/084921 (2004-10-01), None
patent: WO 2004/085630 (2004-10-01), None
U.S. Appl. No. 11/663,570, filed Mar. 23, 2007.
U.S. Appl. No. 11/663,563, filed Mar. 23, 2007.
Doherty, M.J. et al. (1998) “Vascular Pericytes Express Osteogenic Potential In Vitro and In Vitro” J. Bone and Mineral Research 13, pp. 828-838.
Gronthos, S. et al. (2002) “Stem Cell Properties of Human Dental Pulp Stem Cells” J. Dent. Res. 81(8), pp. 531-535.
Jones, E.A. et al (2002) “Isolation and Characterization of Bone Marrow Multipotential Mesenchymal Progenitor Cells” Arthritis & Rheumatism 46(12), pp. 3349-3360.
Shi, S. et al. (2001) “Comparison of Human Dental Pulp and Bone Marrow Stromal Stem Cells by cDNA Microarray Analysis” Bone 29(6), pp. 532-539.
Alberico et al. (1987) Blood 69, p. 1120.
Allen, T.D., “Microenvironments in Haemopoietic and Lymphoid Differentiation” CIBA Found. Symposium 84, pp. 38-67.
Allen et al. (1990) Immunol. Ser. 49, p. 1.
Allen et al. (1990) “Marrow Biology and Stem Cells” Immunol. Ser. 49, pp. 1-38.
Anklesaria et al. (1989) Blood 74, p. 1144.
Anklesaria et al. (1987) Proc. Nat'l Acad. Sci. USA 84, p. 7681.
Bennett et al. (1991) J. Cell Sci. 99, p. 131.
Bentley (1982) Br. J. Haematol 50, p. 1.
Castro-Malaspina et al. (1980) “Characterization of Human Bone Marrow Fibroblast Colony-Forming Cells and Their Progeny” Blood 56, p. 289-301.
Castro-Malaspina et al. (1981) “Human Megakaryocyte Stimulation of Proliferation of Bone Marrow Fibroblasts” Blood 57, p. 781-787.
Clarke, Emer, “Mesenchymal Cells” www.stemcell.com (mini-review).
Dexter et al. (1977) “Conditions Controlling the Proliferation of Haemopoietic Stem Cells in Vitro” J. Cell Physiol. 91, p. 335-344.
Dexter et al. (1984) Kroc Found. Ser. 18, pp. 57-96.
Fong et al. (1997) “Nonradioactive, Agarose Minigel Procedure for Telomeric Repeat Amplification Protocol” BioTechniques 23, p. 1029-1032.
Friedenstein (1976) Int'l R. Cytology 47, p. 327.
Friedenstein (1980) “Stromal Mechanisms of Bone Marrow: Cloning in Vitro and Retransplantation in Vivo” Immunology of Bone Marrow Transplantation, pp. 19-29.
Friedenstein et al. (1970) Cell Tissue Kinetics 3, p. 393.
Friedenstein et al. (1992) Bone and Mineral 18, p. 199.
Gronthos, S., et al. (2003) J. Cell Sci. 116, pp. 1827-1835.
Gronthos, S., et al. (1994) The STRO-1+ Fraction of Adult Human Bone Marrow Contains the Osteogenic Precursors, Blood 84, pp. 4164-4173.
Gronthos, S., et al. (1995) Blood 85, p. 929.
Hellstrom et al. (1999) Development 126, p. 2047.
Huang and Terstappen (1992) Nature 360, p. 745.
Keating et al. (1982) Nature 298, p. 280.
Kim et al. (1994) Science 266, p. 2011.
Knopse et al. (1966) Blood 28, p. 398.
Knopse et al. (1972) Blood 39, p. 331.
Lichtman (1981) Experimental Hematology 9, p. 391.
Long (1992) Experimental Hematology 20, p. 288.
MacManus and Weiss (1984) Blood 64, p. 1036.
McIntyre and Bjornson (1986) Exp. Hematol. 14, p. 833.
Miltenyi et al. (1990) Cytometry 11, p. 231.
Owen (1985) Bone and Mineral Research 3, p. 1.
Owen and Friedenstein (1988) CIBA Found. Symposium 136, p. 42.
Perkins and Fleischman (1990) Blood 75, p. 620.
Piersma et al. (1983) Br. J. Haematol. 54, p. 285.
Rothstein et al. (1985) Blood 65, p. 744.
Simmons and Gronthos (1991) Int'l J. Cell Cloning 9, p. 408 (abstract).
Simmons, P.J., et al. (1994) “Isolation, Characterization and Functional Activity of Human . . . ” Advances in Bone Marrow Purging and Proc.: Fourth Int'l Symp. 389, p. 271-280.
Simmons et al. (1987) Nature 328, p. 429.
Simmons and Torok-Storb (1991) Blood 78, p. 55.
Simmons and Torok-Storb (1991) Blood 78, p. 2848.
Tavassoli and Friedenstein (1983) Ann. J. Hematol. 15, p. 195.
Tavassoli and Crosby (1968) Science 161, p. 54.
Testa et al. (1988) “Long-Term Bone Marrow Damage After Cytotoxic Treatment: Stem Cells and Microenvironment in Hematopoiesis: Long-Term Effects . . . ” Hematol. 8, pp. 75-92.
Van Vlasselaer et al. (1994) Blood 84, p. 753.
Waller et al. (1995) Blood 85, p. 2422.
Weiss (1976) Anatomical Record 186, p. 161.
Zoltowska et al. (2001) Arch. Immunol. Ther. Exp. (Warsz) 49, pp. 59-61.
Axelrad et al., New Technologies for the Enhancement of Skeletal Repair, Injury, Int. J. Care Injured (2007) 38S1:S49-S62.
Bruder et al., Mesenchymal Stem Cells in Bone Development, Bone Repair, and Skeletal Regeneration Therapy, J. Cell Biochem; (1994) 56:283-294.
Dennis et al., Osteogenesis in Marrow-Derived Mesenchymal Cell Porous Ceramic Composites Transplanted Subcutaneously . . . Cell Transplant (1992) 1:23-32, Abstract.
Shi S et al. (2002) “Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.” Journal of Bone and Mineral Research, vol. 17, No. Suppl 1.
Gronthos S et al: “Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.” PNAS of USA, National Academy of Science, 97:5 pp. 13625-13630.
Shi S et al: “Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.” Journal of Bone and Mineral Research, 18:4 pp. 696-704.
Tse H F et al: “Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation.” Lancet The, Lancet Limited,361:9351 pp. 47-49.
Zvaifler, et al., (2000) “Mesenchymal precursor cells in the blood of normal individuals,” Arthritis Research and Therapy, 2: 477-488.
Ji, et al., (2004) “Interactions of Chemokines and Chemokine Receptors Mediate the Migration of Mesenchymal Stem Cells . . .
Gronthos Stan
Simmons Paul
Zannettino Andrew
Angioblast Systems, Inc.
Belyavskyi Michail
Cooper & Dunham LLP
White John P.
LandOfFree
Mesenchymal precursor cell does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mesenchymal precursor cell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mesenchymal precursor cell will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4255438